Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. II)
Katheron Intson

Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. II)

Don't forget to check out Part 1 of our interview with Katheron Intson, where we discussed her background, her research experience in GRIN1, and the reasons behind why she developed…

Continue Reading Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. II)
AllStripes: How this HealthTech Company Leverages Science to Advance Rare Disease Research (Pt. 2)
AllStripes corporate lifestyle photo shoot at Salesforce park and AllStripes offices in San Francisco, Calif., Tuesday, Aug. 17, 2021. Photo by Alison Yin/Alison Yin Photography (Provided to PW by AllStripes)

AllStripes: How this HealthTech Company Leverages Science to Advance Rare Disease Research (Pt. 2)

Nancy Yu co-founded AllStripes with a vision in mind: to unlock more treatment options for those with rare diseases. In Part 1 of our interview, Patient Worthy sat down with…

Continue Reading AllStripes: How this HealthTech Company Leverages Science to Advance Rare Disease Research (Pt. 2)
Improving Rare Disease Clinical Trials
source: pixabay.com

Improving Rare Disease Clinical Trials

Clinical trials face many obstacles regardless of which disease they aim to investigate. However, rare disease trials face additional problems that don't typically impact studies for more common conditions. Small…

Continue Reading Improving Rare Disease Clinical Trials
TRNDS Success!
https://pixabay.com/en/fax-white-male-3d-model-isolated-1889047/

TRNDS Success!

On May 12th, 2017 the University of Rochester Medical Center hosted the first Technology and Rare Neurological Diseases Symposium (TRNDS). It successfully brought together patients, researchers, leaders in health technologies,…

Continue Reading TRNDS Success!